TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture May 3, 1985